Symposium on live biotherapeutic products, held in Amsterdam on April 29–30, 2025. Igor Mierau, Director of Genetic Engineering and Manufacturing, participated as a Key Speaker.
Week of Strategic Meetings in China 2025
During the week of 20–25 October 2025, Aurealis Therapeutics’ CEO Juha Yrjänheikki and COO Laurent Décory traveled to Beijing, Shanghai and Hong Kong for a series of high-level meetings with key stakeholders, investors, and potential partners. The visit aimed to strengthen strategic relationships that support the development and commercialisation of Aurealis’ multi-target cell and gene therapy candidates, AUP-16 for chronic